These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 17014560

  • 1. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.
    Miao L, Sun J, Yuan H, Jia Y, Xu Z.
    Nephrology (Carlton); 2006 Oct; 11(5):449-54. PubMed ID: 17014560
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 3. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
    Yuan H, Liu N, Sun GD, Jia Y, Luo P, Miao LN.
    Pharmacology; 2013 May; 91(5-6):259-66. PubMed ID: 23652322
    [Abstract] [Full Text] [Related]

  • 4. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008 May; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
    Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
    [Abstract] [Full Text] [Related]

  • 7. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids.
    He L, Peng Y, Liu H, Liu Y, Yuan S, Liu F, Yang D, Liu H, Chen X, Shao J, Fu M.
    J Nephrol; 2013 Mar; 26(3):564-71. PubMed ID: 22956434
    [Abstract] [Full Text] [Related]

  • 8. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF, Brodeh J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [Abstract] [Full Text] [Related]

  • 9. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 10. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Apr; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 12. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F, Ayili D, Sahiner S.
    J Nephrol; 2008 Apr; 21(4):560-5. PubMed ID: 18651546
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial.
    Chen W, Liu Q, Liao Y, Yang Z, Chen J, Fu J, Zhang J, Kong Y, Fu P, Lou T, Liu Z, Ji Y, Li Z, Yu X.
    Am J Med Sci; 2013 Feb; 345(2):81-7. PubMed ID: 22627258
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Feb; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome.
    Chen HX, Cheng Q, Li F, He QN, Cao Y, Yi ZW, Wu XC.
    World J Pediatr; 2020 Apr; 16(2):159-167. PubMed ID: 31049814
    [Abstract] [Full Text] [Related]

  • 18. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM, Gamez J, Azem J, Fort JM, López-Cano M, Vilallonga R, Buera M, Armengol M.
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [Abstract] [Full Text] [Related]

  • 19. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 20. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM, Azem J, Fort JM, López-Cano M, Vilallonga R, Gamez J, Armengol M.
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.